Similar articles

• Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients.

  Riethdorf S, Pantel K. Riethdorf S, et al. Breast Cancer Res. 2009;11 Suppl 3(Suppl 3):S10. doi: 10.1186/bcr2429. Epub 2009 Dec 18. Breast Cancer Res. 2009. PMID: 20030861 Free PMC article. No abstract available.
• Disseminated breast tumour cells: biological and clinical meaning.

  Pantel K, Hayes DF. Pantel K, et al. Nat Rev Clin Oncol. 2018 Mar;15(3):129-131. doi: 10.1038/nrclinonc.2017.174. Epub 2017 Nov 21. Nat Rev Clin Oncol. 2018. PMID: 29158590 No abstract available.
• Researchers exploring implications of minimal residual cancer.

  McBride G. McBride G. J Natl Cancer Inst. 2005 Nov 16;97(22):1642-3. doi: 10.1093/jnci/dji422. J Natl Cancer Inst. 2005. PMID: 16288116 No abstract available.
• Circulating tumor DNA in early-stage breast cancer: new directions and potential clinical applications.

  Croessmann S, Park BH. Croessmann S, et al. Clin Adv Hematol Oncol. 2021 Mar;19(3):155-161. Clin Adv Hematol Oncol. 2021. PMID: 33739964 Review.
• DNA array/microarrays in oncological research with focus on pancreatic cancer.

  Baron A, Moore PS, Scarpa A. Baron A, et al. Adv Clin Path. 2001 Oct;5(4):115-20. Adv Clin Path. 2001. PMID: 17582935 Review.